Zobrazeno 61 - 70
of 310
pro vyhledávání: ''
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 43:612-618
Implantation of a left ventricular assist device (LVAD) is a potential treatment in terminal heart failure. Right ventricular (RV) failure is a severe complication in these patients and sometimes requires additional placement of a right ventricular a
Autor:
Masahiro Fujii, David J. Chambers
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 43:619-627
OBJECTIVES: Current cardiac surgery patients are older, sicker, with more diffuse disease and hence a reduced tolerance to ischaemiareperfusion injury. We previously demonstrated that esmolol, an ultra-short-acting β-blocker, can be used as an arres
Autor:
Michael J. Mack, Maurizio Taramasso, Paolo Denti, Ottavio Alfieri, Hugo Vanermen, Volkmar Falk, Francesco Maisano, Joerg Seeburger
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 42:524-529
OBJECTIVES: The aim of the study was to evaluate the technical feasibility and performance of a transcatheter mitral annuloplasty system. METHODS: Adult swines (n= 15) underwent left thoracotomy through the 4th–5th intercostal space. A transcathete
Autor:
Willem den Hengst, Jeroen M.H. Hendriks, Jana Van Thielen, Paul Van Schil, Danielle Van den Weyngaert, Christel De Pooter, Anouk Wittock, Patrick Pauwels
Publikováno v:
European journal of cardiothoracic surgery
OBJECTIVES Isolated lung perfusion with gemcitabine is an effective technique for the treatment of lung metastases in an experimental model. In clinical studies, increased toxicity has been observed when combining intravenous gemcitabine with radioth
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 41:919-925
We previously reported a cardioprotective effect of oral β-glucan in patients who underwent coronary artery bypass grafting. The present study was conducted to determine whether oral β-glucan could reduce myocardial infarction size and whether thes
Autor:
Andrea Mangini, Laurent de Kerchove, Philippe Noirhomme, Gebrine El Khoury, Gianfranco Beniamino Fiore, Joel Price, Carlo Antona, Riccardo Vismara
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 41:1117-1124
Objectives: In aortic valve repair, reduction and stabilization of the ventriculo-aortic junction (VAJ) is generally recommended. In this in vitro study, we compare three techniques of annuloplasty: the subcommissural annuloplasty (SCA), the internal
Autor:
Solveig Moss Kolseth, Idar Kirkeby-Garstad, Øivind Rognmo, Dag Nordhaug, Morten A. Høydal, Sakari Aro, Håvard Nordgaard, Alexander Wahba
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 41:1377-1383
OBJECTIVES: Levosimendan is a novel inotropic agent claimed to improve myocardial contractility by a calcium-sensitizing effect. Our aim was to evaluate dose-dependent effects of levosimendan on left ventricular (LV) contractility and energetic prope
Autor:
Morihito Okada, Koji Arihiro, Takuhiro Ikeda, Yoshihiro Miyata, Yasuhiro Tsutani, Keizo Misumi
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 41:926-932
OBJECTIVES: To repair unexpected damage of the pulmonary artery (PA) during thoracic surgery, fibrinogen/thrombin-based collagen fleece (TachoComb ® [TC]) can be applied as a haemostatic material. The progression of vessel restoration with TC has no
Autor:
Guillermo González-Casaurrán, Elena Vara, Luis Huerta, Ignacio Garutti, Carlos Simón, Jesús Isea, Federico González-Aragoneses, Leire Azcarate
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 41:933-939
OBJECTIVES: Monocyte chemoattractant protein-1 (MCP-1) is believed to play a crucial role in lung ischaemia-reperfusion injury (LIRI). Ischaemic preconditioning (IP) has been shown to protect several organs from ischaemia-reperfusion (IR) injury, alt
Autor:
Valérie Soenen, Alain Wurtz, Ilir Hysi, Thomas Hubert, Carlo Banfi, Christophe Zawadzki, Marie-Christine Copin, Ramadan Jashari
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 41:663-668
OBJECTIVES: Animal studies have demonstrated the feasibility of tracheal replacement by silicone-stented allogenic aortas (AAs), showing mature cartilage regeneration into the grafts. In clinical trials, this graft did not prove stiff enough to allow